Fingerprint
Dive into the research topics of 'Bafetinib, a dual Bcr-Abl/Lyn tyrosine kinase inhibitor for the potential treatment of leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Fabio P.S. Santos, Hagop Kantarjian, Jorge Cortes, Alfonso Quintas-Cardama
Research output: Contribution to journal › Article › peer-review